XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss)
Cumulative Earnings
Cumulative Distributions to Stockholders
Balance at beginning of period at Dec. 31, 2022 $ 1,083,985 $ 0 $ 1,135 $ 2,349,845 $ (68,868) $ 1,153,370 $ (2,351,497)
Beginning balance (in shares) at Dec. 31, 2022     113,484,675        
Increase (Decrease) in Stockholders' Equity              
Net Income 4,620         4,620  
Other comprehensive income 5,832       5,832    
Employee stock purchase and incentive plans (in shares)     379,781        
Employee stock purchase and incentive plans (1,044)   $ 4 (1,048)      
Non-cash equity award compensation and other 6,342     6,342      
Issuance of preferred stock 66,923 66,923          
Preferred dividends declared (1,419)         (1,419)  
Common dividends declared [1] (27,559)           (27,559)
Balance at End of Period at Mar. 31, 2023 1,137,680 66,923 $ 1,139 2,355,139 (63,036) 1,156,571 (2,379,056)
Ending balance (in shares) at Mar. 31, 2023     113,864,456        
Balance at beginning of period at Dec. 31, 2023 1,202,693 66,948 $ 1,315 2,487,848 (57,957) 1,144,412 (2,439,873)
Beginning balance (in shares) at Dec. 31, 2023     131,485,661        
Increase (Decrease) in Stockholders' Equity              
Net Income 30,262         30,262  
Other comprehensive income 9,056       9,056    
Employee stock purchase and incentive plans (in shares)     385,174        
Employee stock purchase and incentive plans (685)   $ 4 (689)      
Non-cash equity award compensation and other 6,697     6,697      
Preferred dividends declared (1,750)         (1,750)  
Common dividends declared [1] (22,110)           (22,110)
Balance at End of Period at Mar. 31, 2024 $ 1,224,163 $ 66,948 $ 1,319 $ 2,493,856 $ (48,901) $ 1,172,924 $ (2,461,983)
Ending balance (in shares) at Mar. 31, 2024     131,870,835        
[1] Includes dividends and dividend equivalents declared on common stock and stock-based compensation awards